Drug firm Zydus Cadila said it has received the final approval from the U.S. health regulator to market Exemestane tablets, used for treatment of brea
from The Hindu - Business https://ift.tt/2C1dYwq
Resent New
Discord abandons Microsoft acquisition talks: Report
Discussion platform Discord, popular among amateur video game players, has halted acquisition talks with Microsoft and is instead considerin...
